"Big Pharm" backing Obamacare?
From the New York Times.
So, is this an "the alligator eats us last" angle, the pharmaceutical industry hoping to nail down an Archer-Daniels-Midland style "government pal" niche in the new system, or a deal in return for keeping the longer-term drug patent rules? Or some combination of these?